| Literature DB >> 34513080 |
A A Kalinin1, V Yu Goloborodko2, V V Shepelev3, Yu Ya Pestryakov3, M Yu Biryuchkov4, E E Satardinova5, V A Byvaltsev6.
Abstract
The aim of the study was to evaluate the effectiveness of the accelerated recovery program for patients with polysegmental degenerative diseases of the lumbar spine. Materials andEntities:
Keywords: ERAS; accelerated recovery after surgery; fast-track surgery; lumbar spine; minimally invasive spinal surgery; multilevel degenerative diseases
Mesh:
Year: 2021 PMID: 34513080 PMCID: PMC8353713 DOI: 10.17691/stm2021.13.2.09
Source DB: PubMed Journal: Sovrem Tekhnologii Med ISSN: 2076-4243
Perioperative management of patients with polysegmental diseases of the lumbar spine
| Criterion | ARP-guided dorsal decompression and stabilization | Traditional dorsal decompression and stabilization | Specialist in charge |
|---|---|---|---|
|
| |||
| Outpatient | In the hospital | Neurosurgeon, anesthesiologist | |
| Outpatient | In the hospital | Anesthesiologist | |
| Several weeks before surgery | No | Anesthesiologist, neurosurgeon | |
| On the day or the eve of the operation | 3–5 days before surgery | Neurosurgeon | |
|
| |||
| Stop taking solid food 6 h before surgery, fluids — 2 h before surgery | Stop taking solid food 18 h before surgery, fluids — 10 h before surgery | Anesthesiologist | |
| Only in the presence of somatic disease | Midazolam, Promedol, Sibazon | Anesthesiologist | |
| Antibiotic prophylaxis 2 h before the first incision | Antibiotic therapy | Anesthesiologist, neurosurgeon, clinical pharmacologist | |
| Yes | Yes | Anesthesiologist, neurosurgeon, sonologist | |
|
| |||
| Yes | No | Anesthesiologist | |
| Yes | No | Neurosurgeon | |
|
| |||
| No drain or its early removal (on day 1) | Mandatory drain for 2–3 days | Neurosurgeon | |
| Removing the urinary catheter in the operating room | After transferring to the post-surgery ward | Anesthesiologist | |
| Multimodal approach | Common use of opiates | Anesthesiologist, neurosurgeon | |
|
| |||
| Upon first hours after surgery and recovery from post-anesthetic depression | After transferring to the post-surgery ward | Physiotherapist, massage therapist | |
| Within the first 12 h after surgery | On the 2nd day after surgery (more than 24 h) | Neurosurgeon, physiotherapy specialist | |
| On the 1st day after surgery | On the 2nd day after surgery (more than 24 h) | Neurosurgeon, physiotherapist | |
| 1–2 days after surgery | 10–14 days after surgery | Neurosurgeon, physiotherapy specialist | |
|
| |||
| Yes | Yes | Expert in rehabilitation, physiotherapist | |
|
| |||
| Yes | Yes | Neurosurgeon, neurologist | |
Patient characteristics
| Indicators | Group 1 (n=24) | Group 2 (n=29) |
|---|---|---|
| Age (years) (Me [25; 75]) | 58 [44; 69] | 55 [41; 68] |
| Gender: | ||
| female/male | 10/14 | 11/18 |
| р±σр% male | 58.3±8.9 | 62.1±11.3 |
| Body mass index (Me [25; 75]) | 25.9 [23.2; 27.3] | 24.5 [23.6; 26.8] |
| Concomitant disease, n (%): | ||
| diabetes | 1 (4.15) | 2 (6.9) |
| arterial hypertension | 2 (8.3) | 3 (10.35) |
| kidney diseases | 1 (4.15) | 1 (3.45) |
| lung diseases | 1 (4.15) | 1 (3.45) |
| coronary artery disease | 2 (8.3) | 2 (6.9) |
| Localization of operated segments, n (%): | ||
| LII–LIII–LIV | 1 (4.15) | 2 (6.9) |
| LIII–LIV–LV | 6 (25.0) | 7 (24.15) |
| LIV–LV–LVI | 4 (16.7) | 5 (17.2) |
| LV–LVI–SI | 2 (8.3) | 1 (3.45) |
| LIV–LV–SI | 11 (45.85) | 14 (48.3) |
Data on surgical operation and postoperative management (Me [25; 75])
| Indicators | Group 1 (n=24) | Group 2 (n=29) |
|---|---|---|
| Duration of operation (min) | 168 [126; 195]* | 256 [208; 324] |
| Duration of anesthesia (min) | 185 [130; 210]* | 270 [215; 340] |
| Blood loss volume (ml) | 75 [50; 130]* | 180 [70; 260] |
| The number of agents administered for anesthesia, 0.005% fentanyl (ml/case) | 20.0 [12.0; 23.5]* | 31 [20.5; 32.5] |
| Verticalization time (days) | 1 [1; 2]* | 2 [1; 2] |
| Duration of inpatient treatment (days) | 9 [7; 9]* | 10 [10; 12] |
* p<0.05 between the groups at the same stages of the study.
Figure 1Severity of pain in the area of surgery as assessed with the visual analogue scale
Figure 2Quality of life according to the SF-36 questionnaire
Adverse effects of anesthesia, n (%)
| Adverse effect | Group 1 (n=24) | Group 2 (n=29) |
|---|---|---|
| Vomiting | — | 1 (3.45) |
| Bradycardia | 1 (4.15) | — |
| Respiratory depression | — | 1 (3.45) |
| Dizziness | 1 (4.15) | 2 (6.9) |
| Nausea | 1 (4.15) | 2 (6.9) |
| Extra time to recover from neuromuscular block | — | 5 (17.2) |
Surgical postoperative complications, n (%)
| Complication | Group 1 (n=24) | Group 2 (n=29) |
|---|---|---|
| Surgery site infection | — | 2 (6.9) |
| Intermuscular hematoma | — | 1 (3.45) |
| Damage to the dura mater | — | — |
| Venous thromboembolic complications | 1 (4.15) | 1 (3.45) |
| Adjacent segment disorder | — | 1 (3.45) |
| Pseudoarthrosis | 1 (4.15) | — |
| Instability of the fixing device | — | 1 (3.45) |